We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 177

Is Valeant’s offer for Allergan the new roadmap for biopharma acquisitions?

  • Kaye Scholer LLP
  • -
  • USA
  • -
  • August 22 2014

Earlier this year, Valeant Pharmaceuticals International, Inc. teamed up with the hedge fund Pershing Square Capital Management, L.P. To acquire

Corporate venture funding for funding surges

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 7 2014

Silicon Valley Bank (SVB) has issued a report that explores health-care and biotech investments and exits based on 2013 data and concludes, "Large

Digital health investments top $2.6B in the first six months of 2014

  • Fenwick & West LLP
  • -
  • USA
  • -
  • July 31 2014

Thanks to an impressive showing in April, digital health investment in the first half of 2014 totaled $2.676 billion. There were a total of 38 deals

Keep the benefit of the bargain reps and warranties survival in healthcare deals

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • July 28 2014

In recent healthcare mergers and acquisitions, we have seen the parties increasingly focus on the survival length of the representations and

9th Circuit affirms dismissal of FCA claim as “implausible” where defendant disclosed its disputed billing methodology to the government

  • Sidley Austin LLP
  • -
  • USA
  • -
  • July 25 2014

On July 22, 2014, the Ninth Circuit issued an important decision supporting the principle that good faith disputes about ambiguous or disputed

Buckle upunwinding Phoebe Putney’s acquisition of Palmyra down in Georgia may end up being back on the table

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • July 21 2014

Almost one year ago, Federal Trade Commission (FTC) agreed to settle its antitrust challenge of Phoebe Putney Health System's (Phoebe Putney

Recent deals highlight the changing role of payors

  • McGuireWoods LLP
  • -
  • USA
  • -
  • June 26 2014

There has recently been significant attention on the role of new players in the healthcare market both nontraditional healthcare investors and

Hospital and health system M&A series: the expanding range of strategic alternatives available in hospital system mergers and acquisitions

  • McDermott Will & Emery
  • -
  • USA
  • -
  • June 24 2014

Significant innovation has occurred in the structures that hospitals and health care systems are using to work together. The focus of this article is

Critical considerations in healthcare affiliations

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 16 2014

The trend of affiliations between healthcare providers (we use the term "affiliation" to include all manner of transactions, including mergers

“Commercially reasonable efforts” diligence obligations in life science M&A

  • McDermott Will & Emery
  • -
  • USA
  • -
  • May 29 2014

More than 80 percent of all deals in the pharmaceutical, medical device and biotech industries include an earnout structure that provides some type